跳至主要内容
临床试验/NCT05391763
NCT05391763招募中不适用

Bilateral Prophylactic Mastectomy; Should we Preserve the Pectoral Fascia?: Protocol of a Dutch Double Blinded, Prospective, Randomized Controlled Pilot Study With a Within-subject Design

Erasmus Medical Center1 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2022年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
21
试验地点
1
主要终点
Drainproduction in milliliters

研究概览

简要总结

Many surgical guidelines promote the removal of the pectoral fascia in mastectomies for invasive breast cancer, but there is no evidence to support this statement in (bilateral) prophylactic mastectomies. Reported wound-related local complications following mastectomy include seroma, flap necrosis, infection, hematoma, and nerve injury. Seroma causes discomfort and may delay the reconstructive procedures. Whether the removal or preservation of the pectoral fascia influences seroma formation following mastectomy remains unclear to our knowledge.

详细描述

The primary objective of this pilot study is to investigate the impact of removal versus preservation of the pectoral fascia on drain policy and needle aspirations in women who undergo a bilateral prophylactic mastectomy. The secondary objective is to investigate the impact of removal versus preservation of the pectoral fascia on postoperative (surgical) complications.

The study design includes a double-blinded, prospective, randomized controlled pilot study with a within-subject design. All patients will undergo a bilateral prophylactic mastectomy and randomization will occur within the patient. Preservation of the PF will be performed in one breast (intervention), while removal of the PF will be performed in the contralateral breast of the same patient (control). Consequently, the operation involves a total bilateral prophylactic mastectomy, with unilateral preservation of the PF

The follow-up time of each patient will be 6 weeks. The patients' files will be viewed after the removal of the drain for additional recorded variables.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

盲法说明

The patient and the observer for drain volume are both blinded for their assigned breast randomization. The surgeon(s) and coordinating researcher will not be blinded, and are therefore not allowed to measure the drain production.

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Female patient
  • Scheduled for a bilateral prophylactic mastectomy in the Erasmus MC Academic Breast Cancer Centre in Rotterdam
  • Ability to give written consent
  • Adequate understanding of Dutch language

排除标准

  • History of diagnosis of invasive breast cancer or ductal carcinoma in situ (DCIS)
  • Other malignancies

结局指标

主要结局

Drainproduction in milliliters

时间窗: Until drain removal, maximum 1 week

The total drainage volume of the left and right breast in milliliters

Time to drain removal in days

时间窗: Until drain removal, maximum 1 week

Number of days until drain removed

次要结局

  • Postoperative bleeding (yes/no)(Up to 6 weeks)
  • Needle aspirations (number)(Up to 6 weeks)
  • Postoperative pain (score 1-10)(Up to 6 weeks)
  • Seroma (yes/no)(Up to 6 weeks)
  • Wound related issues (yes/no)(Up to 6 weeks)
  • Hospitalization duration (in days)(Up to 6 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Linetta Koppert

Principal Investigator

Erasmus Medical Center

研究点 (1)

Loading locations...

相似试验